Jump Trading’s CASI Pharmaceuticals CASI Stock Holding History

Jump Trading’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,632	Closed	-$47K	–	368
2019 Q1	$47K	Buy	+1,632	New	+$56.9K	0.02%	529

Other funds holding CASI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jump Trading's CASI Position: Q2 2019 in Review

Jump Trading sold out of CASI Pharmaceuticals (CASI) in Q2 2019, closing a stake of 1,632 shares — an estimated $47K sold.

Jump Trading first reported a position in CASI in Q1 2019 and held it in 1 quarter. The position peaked at $47K in Q1 2019. 50 funds tracked by Wall St. Rank hold CASI as of Q2 2019.

Jump Trading reported no remaining CASI Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 1,632 CASI Pharmaceuticals shares in Q2 2019, an estimated $47K.
Jump Trading first reported a position in CASI Pharmaceuticals in Q1 2019 and held it in 1 quarter.
Jump Trading's CASI Pharmaceuticals position peaked at $47K in Q1 2019.
50 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.